We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
MedicalSystem

Download Mobile App




Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

Global Sepsis Diagnostics Market Driven by Increasing Prevalence of Bacterial Infections

By LabMedica International staff writers
Posted on 17 Oct 2022
Print article
Image: The global sepsis diagnostics market is expected to surpass USD 1.10 billion by 2027 (Photo courtesy of Pexels)
Image: The global sepsis diagnostics market is expected to surpass USD 1.10 billion by 2027 (Photo courtesy of Pexels)

Sepsis is a potentially fatal condition that occurs when the body's response to an infection causes tissue damage. When the body's infection-fighting processes activate, organs function poorly and abnormally. Sepsis can lead to septic shock, resulting in a significant drop in blood pressure that can cause severe organ damage and death. Sepsis diagnostics include instruments, lab tests, various technologies, and others that are used to diagnose sepsis by examining the patient for signs of infection or organ damage. The global sepsis diagnostics market is expanding due to factors such as the prevalence of the COVID-19 pandemic, an increase in geriatric population, a rise in the prevalence of bacterial infections such as tuberculosis, and increased regulatory approvals for technologically advanced sepsis diagnostics products. As a result, the global sepsis diagnostics market, which was valued at USD 0.65 billion in 2021, is projected to grow at a significant CAGR of 9.60% from 2022 to 2027, to reach USD 1.11 billion.

These are the latest findings of DelveInsight (Las Vegas, NV, USA), a market research firm.

One of the key drivers of the sepsis diagnostics market has been the COVID-19 pandemic. According to the World Health Organization (WHO) data published on 1 July 2022, there were 545,226,550 confirmed cases of COVID-19 across the world. COVID-19 has well-known effects on the respiratory system, with the majority of victims requiring hospitalization for pneumonia of various severity, although almost all other organ systems can be impacted. This is consistent with a mix of sepsis and direct viral invasion. Therefore, sepsis diagnosis is required to verify or check for signs of any infection or organ damage with the disease. Thus, the surge in COVID-19 pandemic cases has boosted the demand for sepsis diagnostics, and further increase in COVID-19 cases is expected to increase the demand for tools, reagents, and test kits for sepsis detection, resulting in growth of the sepsis diagnostics market.

Based on product type, the instruments & kits segment of the sepsis diagnostics market is expected to record a significant growth during the forecast period. Furthermore, the increased regulatory approvals for technologically advanced sepsis diagnostics products may boost the region's overall sepsis diagnostics market. North America is expected to dominate the global sepsis diagnostics market in 2021 and will continue to dominate the market throughout the forecast period due to rising prevalence of bacterial infections such as tuberculosis and increase in regulatory approvals for technologically-advanced sepsis diagnostics products.

Related Links:
DelveInsight 

Gold Supplier
Vaginosis Test
VAGINAL PANEL REALTIME PCR KIT
New
Silver Supplier
Urinalysis Dipstick Control
Dipper Urinalysis Dipstick Control
New
Blood Transfusion Safety Test
ABTest Card
New
EML4-ALK/KIF5B-ALK Fusion Gene Detection Test
QFusion EML4-ALK and KIF5B-ALK Fusion Gene Detection Test

Print article
SUGENTECH INC.

Channels

Clinical Chem.

view channel
Image: ELISA kit for liver-type fatty acid–binding protein (L-FABP). The level of L-FABP present in urine reflects the level of renal tubular dysfunction (Photo courtesy of Sekisui Medical Co)

Urinary Biomarkers Predict Weaning From Acute Dialysis Therapy

Acute kidney injury is associated with a higher risk of chronic kidney disease (CKD), end-stage renal disease, and long-term adverse cardiovascular effects. Critically ill patients with acute kidney injury... Read more

Microbiology

view channel
Image: Ring-form trophozoites of Plasmodium vivax in a thin blood smear (Photo courtesy of Centers for Disease Control and Prevention)

Immune Regulators Predict Severity of Plasmodium vivax Malaria

Cytokines and chemokines are immune response molecules that display diverse functions, such as inflammation and immune regulation. In Plasmodium vivax infections, the uncontrolled production of these molecules... Read more

Pathology

view channel
Image: Breast cancer spread uncovered by new molecular microscopy (Photo courtesy of Wellcome Sanger Institute)

New Molecular Microscopy Tool Uncovers Breast Cancer Spread

Breast cancer commonly starts when cells start to grow uncontrollably, often due to mutations in the cells. Overtime the tumor becomes a patchwork of cells, called cancer clones, each with different mutations.... Read more
Copyright © 2000-2022 Globetech Media. All rights reserved.